Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02451826Phase 2Unknown
Phase 2, randomised, open-label trial of ulipristal in pregnancy, sponsored by Population Council. Primary endpoint: Pharmacodynamic efficacy on the endometrium at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02451826.